Your Complete Monthly Investment Breakdown
12.5mg Mounjaro Monthly Pricing Structure
Your Mounjaro 12.5mg monthly treatment cost with EverydayMeds is straightforward and competitive. Each pen costs £299.99, providing four weeks of once-weekly injections. First-time customers pay just £259.99 using code FIRST40, while returning customers benefit from £25 ongoing savings at £274.99 per month. This prescription-only medication requires clinical assessment before supply.
Maximise Your Monthly Savings
Smart planning can significantly reduce your monthly costs. Our returning customer discount saves you £300 annually compared to standard pricing. Bundle packages offer additional value - the Progress Trio includes your 12.5mg dose alongside stepping stones for £634.99 first order, covering three months of treatment progression. This structured approach may help optimise your treatment journey alongside diet and exercise modifications.
Monthly Budget Planning Made Simple
Month 1: £259.99 (with FIRST40 code) - includes consultation and express delivery. Month 2 onwards: £274.99 per pen with automatic £25 returning customer discount. Annual investment: approximately £3,559.87 including first order savings. Our transparent pricing eliminates surprises, helping you commit confidently to your weight management goals. Express approval available for £25 additional if you need immediate monthly supply.
Flexible Monthly Supply Options
Choose your preferred monthly ordering approach. Single pen orders provide maximum flexibility month-to-month. Bundle packages lock in savings across multiple months while ensuring treatment continuity. Our Progress Trio covers months requiring dose escalation, while single 12.5mg pens suit established treatment phases. All options include our GPhC-registered pharmacy service and clinical oversight throughout your treatment journey.
Start Your Monthly Treatment Today
Don't delay your treatment journey. Order your first 12.5mg Mounjaro pen now for £259.99 delivered. Clinical assessment typically completes within 3 working days, or upgrade to express 24-hour approval. Your monthly investment in prescription-only tirzepatide treatment, designed to activate GIP and GLP-1 hormones, may help regulate appetite and promote feelings of fullness when combined with reduced-calorie diet and increased physical activity.
